In the US, Avelox (moxifloxacin systemic) is a member of the drug class quinolones and is used to treat Bacterial Infection, Bronchitis, Cutaneous Bacillus anthracis, Intraabdominal Infection, Plague, Plague Prophylaxis, Pneumonia, Sinusitis, Skin and Structure Infection, Skin or Soft Tissue Infection and Tuberculosis - Active.
- Avelox (Moxifloxacin Injection)
- Avelox (Moxifloxacin Tablets)
- Avelox I.V.
- Avelox ABC Pack
- Avelox Injection
- AVELOX 400 MG FILM-COATED TABLETS (Leaflet)
- AVELOX 400MG FILM-COATED TABLETS (Leaflet)
- AVELOX 400MG TABLETS (Leaflet)
- AVELOX 400MG/250ML SOLUTION FOR INFUSION (Leaflet)
Ingredient matches for Avelox
Moxifloxacin is reported as an ingredient of Avelox in the following countries:
Moxifloxacin hydrochloride (a derivative of Moxifloxacin) is reported as an ingredient of Avelox in the following countries:
- Bosnia & Herzegowina
- Croatia (Hrvatska)
- Czech Republic
- Hong Kong
- New Zealand
- Russian Federation
- South Korea
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.